Who bills the most Injection, lecanemab-irmb, 1 mg (J0174) to Medicare in Massachusetts?
Medicare Part B FFS · CY2024 · as published by CMS2 physician groups billed Injection, lecanemab-irmb, 1 mg (J0174) to Medicare fee-for-service in Massachusetts in 2024; independent (non-hospital-affiliated) groups deliver 0%.
J0174 — Injection, lecanemab-irmb, 1 mg · Source: CMS Medicare Physician & Other Practitioners PUF (Part B), CY2024 release. Medicare fee-for-service only.
Snapshot covers the whole Massachusetts market — the table below shows the top 100 groups (free tier).
Medicare fee-for-service covers 64% of Medicare in Massachusetts; Medicare Advantage penetration 27% → 36% since 2020.
| # | Physician group | City | St | Specialty | Providers | J0174 svcs | Share* | Phone |
|---|---|---|---|---|---|---|---|---|
| 1 | NEUROLOGY CENTER OF NEW ENGLAND PC | FOXBORO | MA | NEUROLOGY | 14 | 247,597 | 52.9% | (781) 551-5812 |
| 2 | NOVELLA MEDICINE SERVICES OF MASSACHUSETTS PLLC | WATERBURY | MA | NURSE PRACTITIONER | 27 | 105,400 | 22.5% | (203) 706-4982 |
*Share of Massachusetts's disclosed Medicare-FFS services for J0174, counted once per clinician. Volume is placed in the state it was billed from, so this page ranks the groups actually billing J0174 in Massachusetts — including groups registered elsewhere ("City" is each group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group.
How to read this. Figures are Medicare fee-for-service only — not all-payer — from the CMS Medicare Physician & Other Practitioners Public Use File (Part B), CY2024 release. CMS suppresses any provider×code row under 11 beneficiaries, so a missing group means "suppressed," never zero. "Charges" are provider-submitted amounts, not payments. Groups are ranked by measured service volume attributed to clinicians in exactly one group — clinicians affiliated with several groups are listed in rosters but never volume-attributed to a single group — a direct read of the public record, not a rating or quality score. Full method: Methods & Sources.
Comparing against an all-payer estimate?
These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →